These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 9672519

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Mutations in the Fibroblast Growth Factor Receptor 3 gene (FGFR3) in Chilean patients with idiopathic short stature, hypochondroplasia and achondroplasia].
    Mancilla EE, Poggi H, Repetto G, García C, Foradori A, Cattani A.
    Rev Med Chil; 2003 Dec; 131(12):1405-10. PubMed ID: 15022403
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Asn540Lys mutation in fibroblast growth factor receptor 3 and phenotype in hypochondroplasia.
    Grigelioniené G, Eklöf O, Laurencikas E, Ollars B, Hertel NT, Dumanski JP, Hagenäs L.
    Acta Paediatr; 2000 Sep; 89(9):1072-6. PubMed ID: 11071087
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. FGFR3 gene mutations in transmembrane domain in Chinese achondroplasia and hypochondroplasia patients.
    Yan-Ling G, Ji-Hong N, Guo-Qiang L, Wei W, De-Fen W.
    Horm Res; 1998 Sep; 49 Suppl 1():57. PubMed ID: 9554479
    [No Abstract] [Full Text] [Related]

  • 8. [Gly380Arg and Asn540Lys mutations of fibroblast growth factor receptor 3 in achondroplasia and hypochndroplasia in the Spanish population].
    Ezquieta Zubicaray B, Iguacel AO, Varela Junquera JM, Jariego Fente CM, González Gancedo P, Gracia Bouthelier R.
    Med Clin (Barc); 1999 Mar 06; 112(8):290-3. PubMed ID: 10207844
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Achondroplasia-hypochondroplasia complex in a newborn infant.
    Huggins MJ, Smith JR, Chun K, Ray PN, Shah JK, Whelan DT.
    Am J Med Genet; 1999 Jun 11; 84(5):396-400. PubMed ID: 10360392
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia.
    Heuertz S, Le Merrer M, Zabel B, Wright M, Legeai-Mallet L, Cormier-Daire V, Gibbs L, Bonaventure J.
    Eur J Hum Genet; 2006 Dec 11; 14(12):1240-7. PubMed ID: 16912704
    [Abstract] [Full Text] [Related]

  • 15. [Mutations of FGFR3 gene cause 3 types of nanisms with variably severity: achondroplasia, thanatophoric nanism and hypochondroplasia].
    Rousseau F, Bonaventure J, Le Merrer M, Maroteaux P, Munnich A.
    Ann Endocrinol (Paris); 1996 Dec 11; 57(3):153. PubMed ID: 8949408
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of the FGFR3 gene in Japanese patients with achondroplasia and hypochondroplasia.
    Katsumata N, Mikami S, Nagashima-Miyokawa A, Nimura A, Sato N, Horikawa R, Tanae A, Tanaka T.
    Endocr J; 2000 Mar 11; 47 Suppl():S121-4. PubMed ID: 10890199
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.